MENARINI STEMLINE ESPAÑA, S.L.U

Track this competitor Create a free account to be notified when it wins a contract.

Contracts won: 3
Amount won alone: €192,299 excl. VAT
Shared contracts: 2 (multi-supplier framework agreements)
Period: 15 July 2026 – 19 October 2026

Its main clients

CONSORCIO CORPORACIÓ SANITÀRIA PARC TAULÍ DE SABADELL · 1 contract
HOSPITAL UNIVERSITARIO PRINCIPE DE ASTURIAS · 1 contract
Consorci de Salut i d'Atenció Social de Catalunya · 1 contract

Where and what

Supplies · 3

Its contracts coming to an end

So many opportunities to take over these contracts when they are re-tendered.

Planned end	Contract	Current holder	Amount
14 April 2028 re-tender around October 2027	26Far019 c)suministro de medicamentos "exclusivos" (i) CONSORCIO CORPORACIÓ SANITÀRIA PARC TAULÍ DE SABADELL	LABORATORIOS FARMACEUTICOS ROVI, S.A. LUNDBECK ESPAÑA, S.A.U. MENARINI STEMLINE ESPAÑA, S.L.U Merz Therapeutics Iberia S.L. PFIZER, S.L.U. ROCHE FARMA, S.A. TAKEDA FARMACÉUTICA ESPAÑA S.A. 1 bid received	€808,514

Contracts won

Date	Contract	Buyer	Amount
19/10/2026	26Far019 c)suministro de medicamentos "exclusivos" (i)	CONSORCIO CORPORACIÓ SANITÀRIA PARC TAULÍ DE SABADELL	€808,514 shared by 7
02/09/2026	PNSP HUPA 59/26	HOSPITAL UNIVERSITARIO PRINCIPE DE ASTURIAS	€192,299
15/07/2026	Acuerdo marco de suministro de medicamentos oncológicos	Consorci de Salut i d'Atenció Social de Catalunya	€24,435,784 shared by 7

Source: contract award notices published on TED (Publications Office of the European Union), above the EU thresholds. Contracts published only in Belgium are not included yet.